XOM
stock NYSEKey stats
- Open
- $158.42
- +1.37%
- Close
- $155.29
- -0.63%
- Current
- $155.29
- Prev close
- $156.28
- Today
- 17.06M
- 3-mo avg
- 21.17M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 23x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 2.6% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 8.7% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 11.1% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 6.4% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 0.70, the company carries less in liabilities than in equity, a conservative balance sheet.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.15, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue fell 5.0% from the prior year; the top line is contracting.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 14.4% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $285.6B | $413.7B | $344.6B | $349.6B | $332.2B |
| Net income | $23.0B | $55.7B | $36.0B | $33.7B | $28.8B |
| Diluted EPS | $5.39 | $13.26 | $8.89 | $7.84 | $6.70 |
| Dividend / share | $3.49 | $3.55 | $3.68 | $3.84 | $4.00 |
| Total assets | $338.9B | $369.1B | $376.3B | $453.5B | $449.0B |
| Total liabilities | $163.2B | $166.6B | $163.8B | $182.9B | $182.4B |
| Shareholder equity | $175.7B | $202.5B | $212.5B | $263.7B | $259.4B |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $90.8B | $83.1B | $93.1B | $90.0B | $83.1B | $81.5B | $85.3B | $85.1B |
| Net income | $9.1B | $8.2B | $9.2B | $8.6B | $7.7B | $7.1B | $7.5B | $4.2B |
| Diluted EPS | $2.25 | $2.06 | $2.14 | $1.92 | $1.76 | $1.64 | $1.76 | $1.00 |
| Dividend / share | $0.91 | $0.95 | $0.95 | $0.95 | $0.99 | $0.99 | $0.99 | $1.03 |
Recent SEC filings
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report